Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Neuron. Author manuscript; available in PMC Dec 20, 2006.
Published in final edited form as:
PMCID: PMC1713190
Refined Spatial Manipulation of Neuronal Function by Combinatorial Restriction of Transgene Expression
Haojiang Luan,1 Nathan C. Peabody,1 Charles R. Vinson,2 and Benjamin H. White1
1 Laboratory of Molecular Biology, National Institute of Mental Health, NIH, 9000 Rockville Pike, Bethesda, MD 20892
2 Laboratory of Metabolism, National Cancer Institute, NIH, 9000 Rockville Pike, Bethesda, MD 20892
Correspondence to: Benjamin White, National Institute of Mental Health, NIH, 9000 Rockville Pike, Bethesda, MD 20892, Phone: 301-435-5472, Fax: 301-402-0245, E-mail: benjaminwhite/at/
Selective genetic manipulation of neuronal function in vivo requires techniques for targeting gene expression to specific cells. Existing systems accomplish this using the promoters of endogenous genes to drive expression of transgenes directly in cells of interest, or, in “binary” systems, to drive expresssion of a transcription factor or recombinase that subsequently activates the expression of other transgenes. All such techniques are constrained by the limited specificity of the available promoters. We introduce here a combinatorial system in which the DNA-binding (DBD) and transcription activation (AD) domains of a transcription factor are independently targeted using two different promoters. The domains heterodimerize to become transcriptionally competent and thus drive trangene expression only at the intersection of the expression patterns of the two promoters. We use this system to dissect a neuronal network in Drosophila by selectively targeting expression of the cell death gene reaper to subsets of neurons within the network.
Keywords: Gene Targeting, Transgenic, Gal4, Neural Network, Circuit, Drosophila
Understanding how individual neurons, or subsets of neurons, contribute to the development and function of neuronal networks requires techniques for selectively manipulating their function. A growing number of methods exists for perturbing neuronal function by expressing transgenes that affect signalling pathways or cellular viability (reviewed in Miesenbock and Kevrekidis, 2005; White et al., 2001; Wulff and Wisden, 2005), but methods for selectively deploying the expression of these transgenes to specific subsets of neurons remain limited. Binary techniques have proven extremely useful in expressing foreign transgenes in patterns dictated by the promoters of individual endogenous genes (for review see Mallo, 2006), but because most genes are expressed broadly and dynamically, these patterns are rarely restricted enough to map the functional identities of cells within specific developmental lineages or neuronal networks.
To provide further restriction of transgene expression, several ternary techniques have been introduced that place binary gene activation under the control of a third component. In Drosophila, the Gal4-UAS system (reviewed in Duffy, 2002), which uses the yeast transcription factor Gal4 to activate expression of transgenes placed downstream of its unique “upstream activating sequence” or UAS, has been augmented by the addition of the Gal4 repressor, Gal80. Targeting of Gal80 expression to subsets of cells can then be used to restrict gene expression (Suster et al., 2004), in some cases with single-cell resolution, as in the widely used MARCM system (Lee and Luo, 1999). Alternatively, a “Flp-in” technique, which makes UAS-transgene activation contingent on excision of an inserted “stop cassette” by the Flp-recombinase has been used to restrict expression by independently targeting Gal4 and Flp using different promoters (Stockinger et al., 2005). Similarly in mice, transgene activation has been made contingent on the activity of two independently targeted recombinases by coupling Flp to the Crelox system, as in the “intersectional gene activation” technique (Awatramani et al., 2003; Farago et al., 2006).
To date, ternary systems have been developed primarily for use in developmental studies to restrict reporter transgene expression to small numbers of neurons for lineage analysis and fate mapping. Most can, in principle, also be used to drive effector transgene expression to manipulate neuronal function, but usually with certain limitations. Restriction using the MARCM technique, for example, is limited to clonally derived neurons and constrained by the developmental timing of mitosis in the lineages under study. In recombinase-based systems, inefficiency of recombination can limit the extent of gene activation (Ting et al., 2005). Such systems are also intrinsically irreversible.
To develop an alternative ternary approach for versatile functional manipulation of neuronal activity, we have taken advantage of the modularity of transcription factors, which as first shown for the yeast transcriptional activator Gal4 (Brent and Ptashne, 1985; Keegan et al., 1986), often consist of separable functional domains for site-specific DNA-binding (DBD) and transcription activation (AD). Neither domain can activate transcription on its own, but when joined, either covalently or by non-covalent interactions, the two domains can reconstitute site-specific gene expression at appropriate promoter sites. This modularity has been exploited previously in the construction of chimeric transcription factors (Gossen and Bujard, 1992; Wang et al., 1994), and in transcription-based assays for protein interaction domains, such as the widely used yeast two-hybrid system (Fields and Song, 1989). In the “Split Gal4” system described here, we have also exploited this modularity to design DBD and AD domains, which can be independently targeted using different promoters. Each domain is fused to a heterodimerizing leucine zipper fragment so that the two domains bind tightly when expressed together in the same cell to become transcriptionally active. By anchoring the expression of one domain to the expression pattern of one promoter and using other promoters to drive expression of the other domain, transcriptional activity can be reconstituted within restricted regions of the initial pattern. We introduce two implementations of this method in which the DBD of the yeast transcription factor Gal4 is used in conjunction with either the Gal4 AD or the activation domain of the more potent viral transcription factor, VP16. We demonstrate the utility of the system by functionally dissecting a simple neural network involved in wing expansion in Drosophila. We anticipate that the Split Gal4 system will be broadly applicable to problems in which manipulation of cellular function must be rationally restricted.
Development of the Split Gal4 system
To implement the strategy of restricting transgene expression in vivo by independently targeting transcription factor domains, we developed tools that could be deployed in the fruit fly, Drosophila melanogaster, in which the binary Gal4-UAS system for transgene expression is already well-established (Fig. 1A, Brand and Perrimon, 1993). This system includes several hundred transgenic fly lines designed to express reporter and effector transgenes under the control of the “upstream activating sequence” recognized by the Gal4 DBD. We therefore sought to develop a system (Fig. 1B) in which the Gal4 DBD was paired with an AD potent enough to drive transgene expression at levels high enough to permit manipulation of cellular function. Previous studies have indicated that the primary Gal4 AD (i.e. “region II,” Ma and Ptashne, 1987b) coupled with the Gal4 DBD might promote transcription at levels that are only a fraction of those produced by intact Gal4 (Ma and Ptashne, 1987a). We therefore also tested the more potent AD from the Herpes Simplex Virus 1 transcription factor, VP16.
Figure 1
Figure 1
The ternary Split Gal4 System improves upon existing binary expression systems in restricting transgene expression
To optimize transcriptional activity, we fused the Gal4 DBD and the ADs to heterodimerizing leucine zippers, varying the zipper type, site of fusion (N- or C-terminus), and length of the polyglycine spacer between the zipper and the transcription factor domains (see Table S1 for details). The constructs that produced maximal transcriptional activity when co-transfected into Drosophila SL-2 cells are shown schematically in Fig. 2A. These optimal constructs incorporated synthetic leucine zippers based on the chicken B-Zip family member Vitellogenin Binding Protein (Moll et al., 2001). The sequences of these zippers do not match those of Drosophila B-Zip family members (Fassler et al., 2002) and were selected for their strong heterodimerizing and low homodimerizing potentials. Transcriptional activities of the optimal constructs, expressed pairwise in transfected cells and measured in terms of the relative enzymatic activity of a UAS-ß -galactosidase reporter, were 52% and 84% that of intact Gal4 for the Gal4DBD-Gal4AD and the Gal4DBD-VP16AD pairs, respectively (Fig 2B). The individual optimized constructs, which we refer to as “hemidrivers,” displayed little to no transcriptional activity when transfected alone.
Figure 2
Figure 2
Optimized Split Gal4 constructs efficiently drive UAS-reporter gene expression in vitro and in vivo in the Drosophila nervous system
In vivo characterization of the Split Gal4 System
We evaluated the efficacy of the optimized hemidrivers in vivo in three steps, increasing restriction of transgene expression at each step. In Step 1, we created and crossed transgenic lines that expressed each hemidriver throughout the nervous system. This permitted evaluation of each hemidriver’s ability to promote neuronal transgene expression when used in concert with complementary hemidrivers. In addition, it permitted the assessment of possible side effects of each hemidriver’s individual expression. In Step 2, we created lines that expressed each hemidriver in a small set of identified neurons that expresses Crustacean Cardioactive Peptide (CCAP). Crosses of these lines to complementary, pan-neuronal hemidriver lines from Step 1 permitted rigorous evaluation of each hemidriver’s ability to faithfully restrict transgene expression to a set of neurons. In Step 3, we created lines that overlapped in expression pattern with the lines created in Step 2, but only within distinct subset of the CCAP-expressing neurons. This permitted validation of the Split Gal4 system as a tool for mapping the functional identities of defined subsets of neurons. The results obtained at each step of evaluation are discussed in the sections below, with the headings indicating whether the promoters used to express the hemidrivers (P1 and P2) drive transgene expression in a common set of neurons (P1 equals P2), in an included subset (P1 includes P2), or in the intersection of two distinct sets (P1 overlaps P2).
Step 1: Pan-neuronal expression using the Split Gal4 system (P1 equals P2)
Transgenic fly lines that expressed each hemidriver panneuronally were made using the promoter of the elav gene (Yao and White, 1994), and are referred to as elavGal4DBD, elavGal4AD, and elavVP16AD. These lines were viable and healthy, suggesting that expression of the transcription factor constructs throughout the nervous system is not deleterious in itself. In addition, the individual hemidrivers appeared transcriptionally inactive in vivo, just as they were in vitro. The progeny of crosses of each hemidriver line to a line carrying a UAS-EGFP or UAS-EYFP reporter transgene did not exhibit obvious nervous system fluorescence at any stage of development (data not shown). This was true even for homozygous animals containing two copies each of the single hemidrivers and the UAS-EGFP transgenes (Fig. 2C–D), although at long exposure times limited fluorescence was observed in animals expressing two copies of elavGal4DBD (Fig. 2E), suggesting that this hemidriver may have weak transcriptional activity on its own.
In contrast, pairwise crosses of elavGal4DBD and elavGal4AD lines in the presence of a UAS-reporter yielded progeny with bright fluorescence specifically expressed in the central nervous system (CNS; Fig. 2F). We designate crosses in which DBD and AD hemidrivers are paired, with the intersection symbol, ∩ . All Gal4DBD ∩ elav Gal4AD crosses, yielded viable progeny that expressed the reporter transgenes in the nervous system, in some cases at levels approaching that of intact Gal4 (Fig. 2G). Nervous system fluorescence was strong enough to be observed by epifluorescence under a dissection microscope as well as by confocal microscopy from the late embryonic period through adulthood.
Crosses in which the elavGal4DBD and elavVP16AD hemidrivers were paired yielded viable adult progeny with even stronger nervous system fluorescence (Fig. 2H), though, as noted in Experimental Procedures, many of these crosses were lethal. Lethality was independent of reporter gene expression and has not been observed in any other crosses, including those that drive expression in all cholinergic neurons, which comprise much of the fly nervous system, or in broad patterns defined by VP16AD enhancer-trap lines (see below). Overall, our observations strongly indicate that toxicity is not a general feature of VP16AD and Gal4DBD co-expression in neurons, and may instead result from disruption of function in a small number of cells variably represented in the expression pattern of the elav promoter.
Step 2: The Split Gal4 system can faithfully target gene expression to a subset of neurons (P1 includes P2)
To confirm the ability of the Split Gal4 system to restrict transgene expression to a subset of cells within the pattern dictated by a promoter of interest, we first sought to limit UAS-EGFP expression within the nervous system to an identified set of neurons. To this end, we generated a second set of hemidrivers (CCAPGal4DBD, CCAPGal4AD, and CCAPVP16AD) using the promoter for the CCAP gene, which has been demonstrated previously (Park et al., 2003) to be active in approximately 50 neurons of the larval central nervous system (Fig. 3A–B). We then performed pairwise crosses, combining complementary transcription factor domains expressed under the control of the elav and CCAP promoters, and monitored the pattern of expression of a UAS-EGFP reporter transgene in the progeny.
Figure 3
Figure 3
The Split Gal4 system restricts UAS-transgene expression to the intersection of the expression patterns of two promoters
The elavGal4DBD ∩ CCAP Gal4AD crosses resulted in UAS-EGFP expression exclusively within the more restricted CCAP pattern (Fig. 3C), consistent with the reconstitution of transcriptional activity in only cells expressing both transcription factor domains. The reciprocal crosses, namely CCAPGal4DBD ∩ elavGAL4AD, gave similar results (data not shown), and in both cases expression within the CCAP-expressing neurons (NCCAP) was confirmed by double-labeling with an anti-CCAP antibody (Fig. S1A–C). In most crosses, some expression was seen in small numbers of non-CCAP-immunoreactive neurons. This lack of fidelity was similar in exent to that observed with the CCAP-Gal4 driver line created by Park et al. (2003), the expression pattern of which includes non-CCAP-expressing neurons in some animals (see legend, Fig. 3B). With both Gal4 drivers and Split Gal4 hemidrivers, “position effects” resulting from the action of genomic enhancers adjacent to the site(s) of transgene insertion are thus likely to perturb the transcriptional activity of the CCAP-promoter.
We determined the frequency of reporter gene expression in individual CCAP-immunopositive neurons in multiple preparations using the CCAPGal4AD line with the greatest fidelity to create a “consensus expression pattern” as shown in Fig. 3D. Comparison of this pattern with the corresponding consensus expression pattern for the CCAP-Gal4 driver line (Fig. 3B) reveals only slight deviations, with the Split Gal4 cross failing to label two CCAP-expressing neurons in the final abdominal segment.
Gal4 transcriptional activity is regulated in yeast by the Gal80 repressor, which binds to a motif included within the Gal4AD (Ma and Ptashne, 1987a). As shown in Figure S2, Gal80 also efficiently suppresses reporter transgene expression in elavGal4DBD ∩ CCAP Gal4AD crosses when co-expressed under control of the CCAP promoter. The Gal4AD-based implementation of the Split Gal4 system can thus be used in conjunction with the increasing number of transgenic Gal80-expressing fly lines, further extending the range of application of the technique. In particular, coupling the Split Gal4 technique to the TARGET system (McGuire et al., 2003), which exploits a temperature-sensitive Gal80 mutant to temporally regulate Gal4 activity, should permit conditional, as well as spatially restricted, expression of genes of interest.
Restricted expression of the UAS-EGFP reporter within NCCAP was also achieved with the VP16AD construct. The most faithful expression pattern was observed in CCAPGal4DBD ∩ elavVP16AD crosses, when expression of the Gal4DBD domain was anchored to NCCAP (Fig. 3E and Fig. S1D–F). Interestingly, the reciprocal crosses (elavGal4DBD ∩ CCAP VP16AD) resulted in expansion of the expression pattern to include numerous neurons outside of NCCAP with all CCAPVP16AD lines tested (Fig. S1G–I). This infidelity of expression presumably derives from ectopic VP16AD expression and may be the result of a cryptic enhancer in the CCAPVP16AD construct. In any case, it does not affect applications in which precise targeting of the VP16AD hemidriver is unnecessary, such as those using enhancer-trap lines discussed in Step 3. However, the possibility of imprecise targeting of this hemidriver must be considered if defined expression of VP16AD is desired.
To further investigate the selectivity of transgene expression driven by Split Gal4 hemidrivers,, and to confirm the utility of the Split Gal4 system in manipulations of neuronal function, we targeted expression of the cell death gene reaper to NCCAP in elavGal4DBD ∩ CCAP Gal4AD and CCAPGal4DBD ∩ elav VP16AD crosses. As shown in Figure 4A, expression of UAS-reaper under the control of the elav-Gal4 driver, results in early developmental lethality with almost all animials dying at the embryonic or early larval stages. In contrast, reaper expression under control of the CCAP-Gal4 driver results in the two developmental phenotypes first described by Park et al (2003): animals either die as pupae with morphological defects characteristic of head eversion failure, or survive to adulthood without expanding their wings (UW; Fig. 4A). Immunohistochemical examination of animals from such crosses shows that reaper expression by CCAP-Gal4 typically kills most, but not all, of the CCAP-expressing neurons during development (Fig. 4B), whereas control crosses show no neuronal mortality (Fig. 4E).
Figure 4
Figure 4
Genetic ablation of NCCAP neurons using the Split Gal4 system causes pupal lethality and wing expansion deficits that correlate with expression strength
As expected, expression of UAS-reaper using the Split Gal4 system led to pupal lethality and wing expansion deficits at levels that correlated with the extent of NCCAP ablation. In addition, the results better define the different efficacies of the two implementations of the Split Gal4 system. Expression of a single copy of the reaper transgene in NCCAP using the Split Gal4 system with Gal4AD (elavGal4DBD ∩ CCAP Gal4AD) was without effect, but expression of two copies caused wing expansion deficits in 90% of progeny, with little concomitant pupal lethality (Fig. 4A). On average, expression of two copies of UAS-reaper resulted in the death of approximately two-thirds of the NCCAP neurons (Fig. 4C). The Split Gal4 system, implemented with Gal4AD, thus clearly drives reaper expression less potently than intact Gal4 and the absence of the pupal lethal phenotype indicates that the neurons responsible for it were not killed or were killed in insufficient numbers even by two copies of the UAS-reaper transgene. In contrast, expression of a single copy of the reaper transgene in CCAPGal4DBD ∩ elav VP16AD crosses resulted in nearly complete pupal lethality (Fig. 4A) and the death of almost all NCCAP neurons (Fig. 4D), indicating that this implementation of the Split Gal4 system drives reaper expression more potently than intact Gal4. These results are consistent with the levels of EGFP reporter gene expression seen using the two implementations of the system (see Fig. 2F–H). Control crosses expressing single hemidrivers and one or two copies of the reaper transgene produced progeny without pupal mortality or significant wing expansion deficits (Fig. 4A). Overall, our results indicate that the Split Gal4 system drives reaper expression in NCCAP at levels sufficient to ablate some or all of these neurons, with VP16AD providing considerably more potent transgene expression than Gal4AD.
Step 3: The Split Gal4 system can target gene expression to the intersection of two overlapping expression patterns (P1 overlaps P2)
The greatest utility of the Split Gal4 system lies in its potential to limit transgene expression to the intersection of two distinct, but overlapping expression patterns. We describe here an example of this application using two defined promoters. The next section describes a second example using hemidrivers made with undefined promoters (i.e. enhancer-trap lines) to drive gene expression at the intersection of two patterns.
The Gal4AD, with its high degree of fidelity when expressed under a specific promoter, is particularly useful when both the AD and Gal4DBD hemidrivers must be faithfully targeted. We used the CCAPGal4AD in conjunction with a Gal4DBD hemidriver made with the choline acetyltransferase (Cha) promoter (Salvaterra and Kitamoto, 2001) to selectively drive transgene expression in cholinergic NCCAP neurons. Preliminary immunohistochemical studies indicated that at least some NCCAP neurons were cholinergic, and to provide a baseline for assessing the fidelity of ChaGal4DBD ∩ CCAPGal4AD-driven expression, we determined the consensus pattern of Cha promoter activity within NCCAP immunohistochemically (Fig. 5A). As indicated in Figure 5, certain CCAP-immunopositive neurons, such as the bilaterally-represented pairs in the brain (Fig. 5A, B–D), are consistently double-labeled in Cha-Gal4>UAS-EGFP preparations. In the ventral nerve cord, the more-weakly immunopositive member of the pair of CCAP-expressing neurons in hemisegments A1–A4 is also often EGFP-labeled, as shown in the examples of Figure 5E–J, while the strongly immunopositive member of this pair is never EGFP-labeled. In general, we observed considerable variability in the pattern of overlap, suggesting extensive variability of the Cha-Gal4 expression within NCCAP, but the consensus labeling pattern (Fig. 5A), derived from nine double-labeled preparations, shows that 18 of the 48 NCCAP neurons are found within the Cha-Gal4 pattern in greater than a third of the preparations, while thirteen other neurons are found double-labeled at lower frequency.
Figure 5
Figure 5
A subset of NCCAP neurons lies within the expression pattern of the choline acetyltransferase (Cha) promoter, as identified by Cha-Gal4>UAS-EGFP labeling
Figure 6 shows the corresponding results obtained with the Split Gal4 system, in which UAS-EGFP expression was driven by ChaGal4DBD ∩ CCAPGal4AD (Fig. 6A–C). Whole mounts of the CNS from these animals were stained with anti-CCAP antibody (Fig. 6D) to positively identify each EGFP-labeled neuron, and a consensus expression pattern was determined from the examination of multiple animals (Fig. 6I). As with the Cha-Gal4 driver, and therefore unsurprisingly, there was considerable variability in the expression pattern, but in all preparations almost all EGFP-expressing neurons were also CCAP-immunopositive (Fig. 6D), and there was good correspondence in the two consensus expression patterns (compare Fig. 6I with Fig. 5A). In particular, the neurons most frequently observed in the Split Gal4 pattern were the CCAP-immunopositive neurons of the brain (Fig. 6D, arrowheads) and specific hemisegmentally-represented neurons in the ventral nerve cord (Fig. 6D, box). Just as observed with the Cha-Gal4 driver, the latter neurons in hemisegments A1–A4 corresponded to the weakly CCAP-immunopositive neuron of a pair (Fig. 6F–H, and I, box), both of which are equally well labeled by CCAP-Gal4 (Fig. 6E).
Figure 6
Figure 6
Targeting the cholinergic subset of NCCAP, using complementary hemidrivers made with the Cha and CCAP promoters
Restriction of gene expression to arbitrary subsets of cells within a group of interest using VP16AD enhancer-trap hemidrivers
Another strategy for restricting expression within a pattern of interest, particularly useful when there are no known promoters with overlapping expression patterns, uses enhancer-trap lines (Bellen et al., 1989) to express the complementary hemidriver. Enhancer-trap constructs are made with a minimal promoter and express in “arbitrary” patterns dictated by local enhancer elements near the site of transgene integration into the genome. Because the fidelity of expression of the enhancer-trap construct is immaterial, the VP16AD, with its potential for driving transgene expression at high levels, is useful for this application. We therefore made enhancer-trap lines with the VP16AD construct (ETVP16AD) and selected those with expression patterns that overlapped with NCCAP. The broad expression patterns of two such lines (ETVP16AD-N4 and ETVP16AD-N6), revealed by crosses to elavGal4DBD, are shown in Figure 7A and 7C, respectively. The restricted patterns of expression within NCCAP (Fig. 7B), generated by crosses of these lines to CCAPGal4DBD, are shown in Figures 7D and 7F, respectively. As is evident from their consensus expression patterns (Fig. 7E, G), the two enhancer-trap hemidrivers limit expression to two nearly mutually exclusive subsets of NCCAP. ETVP16AD-N4 crosses to CCAPGal4DBD drive expression almost exclusively in neurons of the subesophageal and thoracic ganglia, while those of ETVP16AD-N6 drive expression primarily in the brain and abdominal ganglia.
Figure 7
Figure 7
Split Gal4 enhancer-trap lines can be used to target distinct subsets of neurons within NCCAP
Dissection of neural network function using the Split Gal4 system
Having identified enhancer-trap lines capable of selectively expressing transgenes in discrete subsets of NCCAP, we next used them to probe the functional identities of the neurons within this group. As indicated above, NCCAP plays a critical role in wing expansion in the early adult and we wished to determine which neurons within this group might be necessary and/or sufficient for this process. We therefore ablated the subsets of NCCAP neurons included in the ETVP16AD-N4 and ETVP16AD-N6 expression patterns using UAS-reaper, and correlated the patterns of the surviving NCCAP neurons with the wing expansion phenotype.
We used anti-CCAP immunostaining of the nervous system to assess the patterns of surviving NCCAP neurons (Fig. 8A, E). Because the CCAP-expressing neurons apoptose shortly after eclosion (Draizen et al., 1999), it was necessary to evaluate the patterns of the surviving NCCAP neurons in pharate adults, that is, at a stage just before eclosion and wing expansion. Therefore, we could not compare wing expansion with the surviving NCCAP neurons in individual animals. To help identify these neurons, which differ somewhat in number and position from those of the larval stage, we double-labeled the preparations with an antibody to the hormone bursicon (Fig. 8B–C, F–G), which is expressed in a subset of NCCAP, including 14 neurons in the abdominal ganglion (Fig. 8I). Ablations performed using the ETVP16AD-N4 hemidriver primarily affected neurons of the subesophageal and thoracic ganglia (Fig. 8D, black circles), as expected from the expression pattern in third-instar larvae (Fig. 7E). Six abdominal ganglion neurons that appear in the expression pattern only during pupal development (data not shown), and which do not express bursicon, were also ablated. In contrast, ablations performed using the ETVP16AD-N6 hemidriver mostly spared the neurons of the thoracic and subesophageal ganglia, but eliminated, on average, 12 of the 30 abdominal ganglion neurons, including nine that express bursicon (Fig. 8H). Interestingly, only ablations performed with the ETVP16AD-N4 hemidriver yielded animals that failed to expand their wings (Fig. 8J). This effect was not fully penetrant, but because there were slight variations in the patterns of cell death from animal to animal (see Fig. 8C, legend), it is likely that the 15% of animals that expanded their wings normally corresponded to those in which some small number of critical neurons were not killed.
Figure 8
Figure 8
Genetic ablation of neurons within NCCAP using the Split Gal4 system identifies anatomically and functionally distinct subsets of this network
The two lines therefore identify functionally, as well as anatomically, distinct subsets of NCCAP. The set of neurons surviving the ablation with ETVP16AD-N6 (Fig. 8H, red) is clearly sufficient to support wing expansion, and the set surviving ablation with ETVP16AD-N4 (Fig. 8D, red) is insufficient for wing expansion. Conversely, some or all of the neurons ablated in crosses using ETVP16AD-N4 (Fig. 8D, black circles) must be necessary for wing expansion. If we remove from this latter group the small number of neurons that are clearly unnecessary, because they are ablated without effect in ETVP16AD-N6 crosses (e.g. the middle pair of subesophageal neurons), we are left with a minimal subset of neurons, some or all of which must be necessary for wing expansion (Fig. 8K, red).
This “critical subset” represents part of a larger group of previously identified neurons, and our results with the Split Gal4 system confirm and extend an earlier model of NCCAP function. Previously, we showed that neurons within NCCAP act as a small network with output and regulatory functions, both of which are necessary for wing expansion (Luan et al., 2006). The critical subset identified here (Fig. 8K–L, red filled) definitively implicates several neurons within the broad group previously identified as candidate regulatory neurons as required for wing expansion (Fig. 8L, blue circles). However, as can be seen in Fig. 8L, the critical subset cannot be sufficient for wing expansion, since it does not include any of the 14 bursicon-expressing neurons that comprise the output group (green circles). As shown in Fig. 8H, ablation of up to nine of the bursicon-expressing neurons with ETVP16AD-N6 does not compromise wing expansion, suggesting that some or all of the remaining five bursicon-expressing neurons are necessary. Alternatively, it is possible that the output function is distributed, and that various subsets of the output group are sufficient to promote wing expansion. Although further work with other enhancer-trap lines and other effectors will be required to elucidate the individual functional identities of neurons within NCCAP, this example illustrates how the Split Gal4 system can be used to systematically subdivide and define the functional elements of a neuronal circuit.
The Split Gal4 technique introduced here is a general and versatile method for targeting transgene expression to subsets of neurons within a pattern of interest. Because it uses the Gal4DBD, it is compatible with the hundreds of UAS-effector lines already available in Drosophila. Its implementation using the Gal4AD also makes it compatible with the growing number of Gal80 lines and permits an additional level of spatial or temporal control. The two implementations of the technique presented have complementary strengths. The Gal4AD, although weaker than the VP16AD, can drive effector transgene expression at levels sufficient to manipulate neuronal viability and function, and can be targeted with high fidelity when used with specific promoters. The VP16AD, as we have shown, is better-suited for use in enhancer-trap constructs where its lower promoter fidelity is unproblematic and its higher transcriptional activity permits even weak effector transgenes to be used at single-copy dosages. Although expression of the VP16AD together with the GalDBD may be toxic in a small population of neurons, as evidenced by the general lethality of panneuronal expression, such toxicity is clearly not the rule, as we have not observed it in any other application, including applications using VP16AD enhancer trap lines with broad expression in the nervous system (Fig. 7A, C).
We have demonstrated the utility of the Split Gal4 technique in the field of neuronal circuit analysis, where we expect it will find fertile application. It should be possible to use the technique not only to subdivide known neuronal groups, but also to perform screens analogous to current Gal4 enhancer-trap screens to identify as yet unknown neuronal substrates of physiological processes or behaviors. Unlike current screens, however, it should be possible to use the Split Gal4 technique iteratively, to successively refine the identification of neuronal substrates within a group of interest once it is identified, as outlined in Figure S3. The level of resolution attainable with the Split Gal4 system may vary depending on the homogeneity of gene expression in the cell group of interest, but given the high degree of neuronal specialization normally observed, this is unlikely to be a major limitation. We also anticipate that the usefulness of the Split Gal4 system introduced here will extend beyond the nervous system to other tissues and other fields of research. Finally, while we have implemented the Split Gal4 technique in Drosophila, there is no reason it cannot be implemented in other genetic model organisms, such as zebrafish or mice, where similar transcriptional systems for the expression of foreign genes exist.
Generation of Optimized Hemidriver Constructs
The optimized Gal4DBD, Gal4AD and VP16AD constructs used for in vitro testing were assembled between the EcoRV and HpaI restriction sites (Fig. S4A) in the pActPL vector (Wei et al., 2000) using PCR fragments corresponding to the transcription factor, polyglycine linker and the heterodimerizing leucine zipper domains. Transcription factor PCR templates were made to pGBKT7 (Clontech), pGADT7 (Clontech), and pUHD15-1 (Resnitzky et al., 1994) and were designed to amplify sequences encoding amino acids 1-147 (Gal4 DBD) and 768–881 (Gal4AD) of Gal4, and 413–490 (VP16AD) of VP16, respectively. The heterodimerizing leucine zipper domains corresponded to the RR12EE345L (Zip−) and EE12RR345L (Zip+) sequences described by Moll et al. (2001) and were generated from synthetic oligonucleotides with codon usage optimized for Drosophila expression. A point mutation inadvertently introduced by PCR resulted in a Y → Nmutation at amino acid 36 in the EE12RR345L domain used in the Gal4AD and VP16AD constructs. The transcription factor sequences of all pActPL constructs are flanked by unique restriction sites at the 5’ (NotI) and 3’ (AscI) ends.
Generation of Transformation Vectors and Transgenic Fly Lines
The elavGal4DBD, elavGal4AD, and elavVP16AD transformation constructs used to make transgenic flies were made from the pCaST vector as described in Fig. S4B. This vector was derived from pP{elav-GeneSwitch} (Osterwalder et al., 2001) by replacing an EcoRI-XbaI fragment containing the elav-promoter and GeneSwitch sequences with a polylinker containing EcoRI–BglII–NotI–AscI–XbaI restriction sites to make pCaST. The ChaGal4DBD, CCAPGal4DBD, CCAPGal4AD, and CCAPVP16AD transformation constructs were generated from a derivative of pCaST, called X11 (Fig. S4C), which was made by replacing the EcoRI-elav-NotI fragment of pCaST-elavGal4DBD with a polylinker containing EcoRI-AvrII-BglII-PmeI-NotI sites. The enhancer trap constructs ETGal4AD and ETVP16AD were made by inserting NotI-Gal4AD-AscI and NotI-VP16AD-AscI fragments into pEG117 (Giniger et al., 1993), after replacing the KpnI site in the polylinker of this vector by AscI (Fig. S4D).
Generation and Characterization of Transgenic Fly Lines
P-element injections and isolation of transformants were performed for all plasmids by Genetic Services, Inc. Six to fourteen independent lines were made for each construct, and the chromosomal locations of the transgenes was determined by segregation analysis. In Step 1, a UAS-EYFP or UAS-EGFP transgene was introduced into the elavGal4DBD lines and these lines were crossed pairwise with elavGal4AD and elavVP16AD lines to determine viability and fluorescence expression levels of the progeny. Of the 10 elavGal4DBD lines we made, only one (elavGal4DBD-H9) yielded viable adult progeny in pairwise crosses to elavVP16AD hemidrivers. Crosses made with the other nine lines died as embryos or early larvae. Neither the pattern nor levels of fluorescence in these embryos differed overtly from those observed in embryos from viable crosses, and in all cases the fluorescence intensity was very high. The mortality is unlikely to be due either to toxicity of the highly expressed reporter, since identical crosses lacking a UAS-transgene also failed to yield viable progeny, or to transcriptional squelching (Cahill et al., 1994), since animals expressing only the elavVP16AD construct are viable and healthy.
Transgenic lines generated in Steps 2 and 3 were characterized similarly to those generated in Step 1. Consensus expression patterns were derived for at least two independent CCAPGal4 DBD, CCAPGal4AD, and CCAPVP16AD lines by multiple pairwise crosses to complementary panneuronal hemidrivers. Independent lines expressing the same construct, had similar consensus patterns in all cases. In Step 3, consensus patterns were determined for three independent ChaGal4DBD lines in pairwise crosses to two independent CCAPGal4AD lines.
Other Fly Stocks
The Gal4 driver and UAS-reporter/effector lines used in this study: yw; +; CCAP-Gal4 (Park et al., 2003); yw; UAS-2XEGFP; UAS-2XEGFP (Halfon et al., 2002) and yw; +; elav-Gal4 (Luo et al., 1994); w; Cha-Gal4-19B; + (Salvaterra and Kitamoto, 2001). The w; rpr; + and Canton-S lines were from the Bloomington Stock Center. yw; CCAP-Gal80; Dr/TM3,Sb (ET1–B1A) is a second chromosome insert of the construct described in Luan et al. (2006). All flies were raised on standard corn meal-molasses medium and maintained at 25°C/65% relative humidity on a constant 12 h light/dark cycle.
Cell Culture, Transfection and ß-galactosidase Activity Measurement
Drosophila SL2 cells were cultured and transfected according to previously described methods (Wei et al., 2000). For each measurement, 2x106 cells were transfected 24 h after plating using Fugene 6 (Roche Diagnostics) and 2 μg of plasmid(s). Plasmids included pActPL vectors containing the intact Gal4, Gal4DBD, Gal4AD, and/or VP16AD transcription factor constructs, together with a UAS-nucLacZ reporter plasmid. The pRmHa3’ vector was used as a carrier when necessary to insure addition of the same amount of DNA in all transfections. 72 hours after transfection, cells were lysed and ß-galactosidase activity was quantified using the ß-gal Reporter Gene Assay, Chemiluminescent Kit (Roche Diagnostics).
Immunohistochemistry and Microscopy
Wandering 3rd instar larvae or late-stage, black-winged pharate adults were dissected in PBS, and the excised nervous systems were fixed, permeabilized, and stained as described previously (Luan et al., 2006). Antibody labeling was carried out with rabbit anti-CCAP (Ewer and Truman, 1996) at 1:5000 dilution, and mouse anti-bursicon ß-subunit (Luo et al., 2005), at 1:250 dilution. AlexaFluor-488-coupled goat-anti-rabbit and AlexaFluor-596-coupled goat-anti-mouse fluorescent secondary antibodies were from Invitrogen. Whole mount preparations were imaged with a Nikon C-1 confocal microscope. Optical sections were acquired using a 20X objective or 40X objective for all figures except the high-resolution images of anti-CCAP immunostaining shown in Fig.s 5B–J and 6E–H, which were acquired using a 60X oil immersion objective. All images of the brain and ventral nerve cord are volume-rendered Z-stacks.
Analysis of expression patterns and immunoreactivity
UAS-EGFP expression driven by intact Gal4 or by Split Gal4 hemidrivers varied somewhat between individuals. To represent the frequency and intensity of UAS-EGFP expression in individual identified NCCAP neurons, we created consensus expression patterns derived from multiple CNS preparations of each genotype. Each image from the confocal Z-stack containing a CCAP-immunopositive neuronal soma was then evaluated for overlapping UAS-EGFP expression. The intensity (I) of labeling of each soma was scored on a scale of 0 – 3. The consensus intensity value for each identified CCAP-expressing neuron was calculated by averaging all values for this neuron across preparations. In the consensus patterns for 3rd instar larvae, cells with average values of I ≥ 2 are represented as filled circles. Open circles have average values of 0<I<2. The frequency with which each neuron expressed EGFP was equal to the number of preparations in which I≠0 for that neuron divided by the total number of preparations, and is represented as described in the figure legends.
For experiments in which reaper was used to ablate CCAP-expressing neurons, the number and identity of the surviving cells was determined by examining anti-CCAP and/or anti-bursicon labeled preparations imaged by confocal microscopy. Surviving neurons in each preparation were counted and the means and standard deviations calculated for all preparations within an experiment. In the consensus patterns of Fig. 8, a cell is represented as “ablated” if it was present in less than one-third of the samples.
Analysis of Lethality and Wing Expansion Phenotypes
The UAS-reaper transgene used for genetic ablation in this paper is less potent than the one used previously by Park et al. (2003), and was selected to better distinguish the relative efficacies of the Gal4AD and VP16AD hemidrivers. In ablation experiments, wing phenotypes were scored as described in Luan et al. (2006), at least 24 h after eclosion to ensure that the final phenotype had been attained. Pupal mortality was assessed 7 days after a cross had been terminated and all live animals had eclosed, by dividing the number of dead pupae by the total number of live progeny plus dead pupae generated by the cross.
We would like to acknowledge John Ewer, Cahir O’Kane, Haig Keshishian, Toshihiro Kitamoto, and the Bloomington Stock Center for providing fly stocks and the National Institute of Neurological Disorders and Stroke sequencing facility for services. We also thank Paul Salvaterra, Jae Park, Ed Giniger, Bruce Patterson, Chihon Lee, and Marc Halfon for plasmids, and John Ewer, and Aaron Hsueh for antibodies. Bruce Paterson also kindly provided cell lines. We also express our appreciation to Grace Gray, Chi-hon Lee, and Harold Gainer for comments on the manuscript, and to Howard Nash who provided sound advice and enthusiastic encouragement throughout the project. This research was supported by the Intramural Research Programs of the National Institute of Mental Health (B.H.W) and the National Cancer Institute (C.R.V.), NIH.
  • Awatramani R, Soriano P, Rodriguez C, Mai JJ, Dymecki SM. Cryptic boundaries in roof plate and choroid plexus identified by intersectional gene activation. Nat Genet. 2003;35:70–75. [PubMed]
  • Bellen HJ, O'Kane CJ, Wilson C, Grossniklaus U, Pearson RK, Gehring WJ. P-element-mediated enhancer detection: a versatile method to study development in Drosophila. Genes Dev. 1989;3:1288–1300. [PubMed]
  • Brand AH, Perrimon N. Targeted Gene-Expression As A Means Of Altering Cell Fates And Generating Dominant Phenotypes. Development. 1993;118:401–415. [PubMed]
  • Brent R, Ptashne M. A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor. Cell. 1985;43:729–736. [PubMed]
  • Cahill MA, Ernst WH, Janknecht R, Nordheim A. Regulatory Squelching. Febs Letters. 1994;344:105–108. [PubMed]
  • Draizen TA, Ewer J, Robinow S. Genetic and hormonal regulation of the death of peptidergic neurons in the Drosophila central nervous system. J Neurobiol. 1999;38:455–465. [PubMed]
  • Duffy JB. GAL4 system in Drosophila: a fly geneticist's Swiss army knife. Genesis. 2002;34:1–15. [PubMed]
  • Ewer J, Truman JW. Increases in cyclic 3', 5'-guanosine monophosphate (cGMP) occur at ecdysis in an evolutionarily conserved crustacean cardioactive peptide-immunoreactive insect neuronal network. J Comp Neurol. 1996;370:330–341. [PubMed]
  • Farago AF, Awatramani RB, Dymecki SM. Assembly of the brainstem cochlear nuclear complex is revealed by intersectional and subtractive genetic fate maps. Neuron. 2006;50:205–218. [PubMed]
  • Fassler J, Landsman D, Acharya A, Moll JR, Bonovich M, Vinson C. B-ZIP proteins encoded by the Drosophila genome: Evaluation of potential dimerization partners. Genome Research. 2002;12:1190–1200. [PubMed]
  • Fields S, Song O. A novel genetic system to detect protein-protein interactions. Nature. 1989;340:245–246. [PubMed]
  • Giniger E, Wells W, Jan LY, Jan YN. Tracing Neurons With A Kinesin-Beta-Galactosidase Fusion Protein. Rouxs Archives Of Developmental Biology. 1993;202:112–122.
  • Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 1992;89:5547–5551. [PubMed]
  • Halfon MS, Gisselbrecht S, Lu J, Estrada B, Keshishian H, Michelson AM. New fluorescent protein reporters for use with the Drosophila Gal4 expression system and for vital detection of balancer chromosomes. Genesis. 2002;34:135–138. [PubMed]
  • Keegan L, Gill G, Ptashne M. Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein. Science. 1986;231:699–704. [PubMed]
  • Lee T, Luo L. Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis. Neuron. 1999;22:451–461. [PubMed]
  • Luan H, Lemon WC, Peabody NC, Pohl JB, Zelensky PK, Wang D, Nitabach MN, Holmes TC, White BH. Functional dissection of a neuronal network required for cuticle tanning and wing expansion in Drosophila. J Neurosci. 2006;26:573–584. [PMC free article] [PubMed]
  • Luo CW, Dewey EM, Sudo S, Ewer J, Hsu SY, Honegger HW, Hsueh AJ. Bursicon, the insect cuticle-hardening hormone, is a heterodimeric cystine knot protein that activates G protein-coupled receptor LGR2. Proc Natl Acad Sci U S A. 2005;102:2820–2825. [PubMed]
  • Luo L, Liao YJ, Jan LY, Jan YN. Distinct morphogenetic functions of similar small GTPases: Drosophila Drac1 is involved in axonal outgrowth and myoblast fusion. Genes Dev. 1994;8:1787–1802. [PubMed]
  • Ma J, Ptashne M. The Carboxy-Terminal 30 Amino-Acids Of Gal4 Are Recognized By Gal80. Cell. 1987a;50:137–142. [PubMed]
  • Ma J, Ptashne M. Deletion Analysis Of Gal4 Defines 2 Transcriptional Activating Segments. Cell. 1987b;48:847–853. [PubMed]
  • Mallo M. Controlled gene activation and inactivation in the mouse. Front Biosci. 2006;11:313–327. [PubMed]
  • McGuire SE, Le PT, Osborn AJ, Matsumoto K, Davis RL. Spatiotemporal rescue of memory dysfunction in Drosophila. Science. 2003;302:1765–1768. [PubMed]
  • Miesenbock G, Kevrekidis IG. Optical imaging and control of genetically designated neurons in functioning circuits. Annual Review Of Neuroscience. 2005;28:533–563. [PubMed]
  • Moll JR, Ruvinov SB, Pastan I, Vinson C. Designed heterodimerizing leucine zippers with a range of pIs and stabilities up to 10(−15) M. Protein Science. 2001;10:649–655. [PubMed]
  • Osterwalder T, Yoon KS, White BH, Keshishian H. A conditional tissue-specific transgene expression system using inducible GAL4. Proc Natl Acad Sci U S A. 2001;98:12596–12601. [PubMed]
  • Park JH, Schroeder AJ, Helfrich-Forster C, Jackson FR, Ewer J. Targeted ablation of CCAP neuropeptide-containing neurons of Drosophila causes specific defects in execution and circadian timing of ecdysis behavior. Development. 2003;130:2645–2656. [PubMed]
  • Resnitzky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol. 1994;14:1669–1679. [PMC free article] [PubMed]
  • Salvaterra PM, Kitamoto T. Drosophila cholinergic neurons and processes visualized with Gal4/UAS-GFP. Brain Res Gene Expr Patterns. 2001;1:73–82. [PubMed]
  • Stockinger P, Kvitsiani D, Rotkopf S, Tirian L, Dickson BJ. Neural circuitry that governs Drosophila male courtship behavior. Cell. 2005;121:795–807. [PubMed]
  • Suster ML, Seugnet L, Bate M, Sokolowski MB. Refining GAL4-driven transgene expression in Drosophila with a GAL80 enhancer-trap. Genesis. 2004;39:240–245. [PubMed]
  • Ting CY, Yonekura S, Chung P, Hsu SN, Robertson HM, Chiba A, Lee CH. Drosophila N-cadherin functions in the first stage of the two-stage layer-selection process of R7 photoreceptor afferents. Development. 2005;132:953–963. [PubMed]
  • Wang Y, O'Malley BW, Jr, Tsai SY, O'Malley BW. A regulatory system for use in gene transfer. Proc Natl Acad Sci U S A. 1994;91:8180–8184. [PubMed]
  • Wei Q, Marchler G, Edington K, Karsch-Mizrachi I, Paterson BM. RNA interference demonstrates a role for nautilus in the myogenic conversion of Schneider cells by daughterless. Dev Biol. 2000;228:239–255. [PubMed]
  • White BH, Osterwalder TP, Yoon KS, Joiner WJ, Whim MD, Kaczmarek LK, Keshishian H. Targeted attenuation of electrical activity in Drosophila using a genetically modified K(+) channel. Neuron. 2001;31:699–711. [PubMed]
  • Wulff P, Wisden W. Dissecting neural circuitry by combining genetics and pharmacology. Trends Neurosci. 2005;28:44–50. [PubMed]
  • Yao KM, White K. Neural Specificity Of Elav Expression - Defining A Drosophila Promoter For Directing Expression To The Nervous-System. Journal Of Neurochemistry. 1994;63:41–51. [PubMed]